Carasent Q4: Initial take

Research Note

2022-02-10

10:00

Redeye comments on Carasent's Q4 report, which was slightly weaker than expected, partly due to issues stemming from the pandemic. However, there were several positive points as well, such as the green light for Webdoc X after a trial phase, salesforce recruitment as outbound sales showed promise, and key personnel recruitment in Norway, ready to sell Webdoc NO.

MS

Mark Siöstedt

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.